Table 2.
Causes of hospital admission and clinical outcome in HTLV-1-incted patients
| Final diagnoses | |
| Infectious complications | 138/582 (23.7) |
| HAM/TSP | 86/582 (14.8) |
| ATLL | 73/582 (12.5) |
| ATLL complications* | 69/582 (11.9) |
| HAM/TSP complications** | 18/582 (3) |
| Other types of neoplastic disorders*** | 18/582 (3) |
| Unknown | 14/582 (2.4) |
| CTCL/Sezary syndrome | 12/582 (2.1) |
| Neurologic complications^ | 12/582 (2.1) |
| Rheumatologic disorders# | 11/582 (1.9) |
| Cardiovascular complications@ | 20/582 (3.4) |
| Others | 111/582 (19) |
| LOS | 7 (3, 12) |
| In-hospital mortality | 98/582 (16.8) |
*Such as Chemotherapy, Hypercalcemia, Reaction to chemotherapy medications, Packed cell injection, ATLL relapse
** Such as Corticosteroid pulse, HAM/TSP exacerbation
*** Such as NHL, DLBL, Lung cancer, Thyroid cancer, Pancreatic cancer, Multiple myeloma
^ Such as HTLV-1 induced- polyneuropathy, Neurogenic bladder
# Such as Systemic Lupus Erythematous, Wegner Granulomatosis, Still Disease, Dermatomyositis, Inclusion body myositis
@ Such as Acute coronary syndrome, Heart failure, Ischemic Heart Disease, Deep Venous Thrombosis, Pulmonary Thrombo-Embolism